Successful use of anifrolumab in refractory cutaneous lupus erythematosus with systemic lupus erythematosus: A case report
A 61-year-old female with systemic lupus erythematosus presented with refractory discoid lupus. Despite treatment with numerous immunosuppressive therapies, including prednisone, hydroxychloroquine and mycophenolate mofetil, her cutaneous lupus remained active and significantly impacted her quality...
Saved in:
Main Authors: | Abdullah Ramadhan, Anita Troung, Elaine Yacyshyn, Robert Gniadecki |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2025-06-01
|
Series: | SAGE Open Medical Case Reports |
Online Access: | https://doi.org/10.1177/2050313X251350376 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Experience of using Anifrolumab in the treatment of patients with systemic lupus erythematosus
by: E. V. Bolotova, et al.
Published: (2025-03-01) -
The role of anifrolumab in reshaping the treatment landscape of extra-renal systemic lupus erythematosus
by: Fulvia Ceccarelli, et al.
Published: (2025-07-01) -
Portrait of a patient with systemic lupus erythematosus for the prescription of the type I interferon inhibitor anifrolumab
by: T. M. Reshetnyak, et al.
Published: (2023-12-01) -
EXANTHEMATOUS LUPUS ERYTHEMATOSUS
by: N.S. Podchernyaeva, et al.
Published: (2006-12-01) -
Real-world effectiveness of belimumab and anifrolumab in systemic lupus erythematosus: comparable trends in disease activity and glucocorticoid reduction
by: Ryota Sato, et al.
Published: (2025-07-01)